Portable Endoscopic Camera System Using Modified Action Camera for Endoscopic Sinunasal Examination

NCT ID: NCT07289854

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-16

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to compare two methods for performing a nasal endoscopic examination used in the evaluation of excessive watering or tearing of the eyes. The purpose of the study is to determine whether a new, smaller, modified camera system can produce images of the inside of the nose that are as clear and useful as those produced by the standard endoscopic camera system currently used in clinics.

The study seeks to answer the question of whether a compact, easy-to-store camera system can provide similar diagnostic image quality to the traditional, larger tower-based system. The clinical steps of the nasal examination remain the same; the only difference is the type of camera system used to capture the images.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study evaluates two imaging systems used during routine nasal endoscopy performed for assessment of epiphora and related nasolacrimal or sinonasal concerns. The protocol involves conducting a standard nasal endoscopic examination with the conventional full-size tower-mounted camera system typically utilized in ophthalmology and otolaryngology outpatient settings, followed by a second examination using a modified compact camera system. Both examinations use the same endoscope and follow identical clinical steps.

The modified camera system attaches at the usual hand-position point on the endoscope and is designed to reduce equipment footprint, increase portability, and simplify storage. The second examination adds an estimated 3-5 minutes to the clinical encounter and does not introduce additional maneuvers or diagnostic procedures.

The primary objective is to compare image quality between the standard system and the compact system. Secondary objectives include assessments of device usability, handling characteristics, and overall feasibility of integrating the compact system into routine clinical workflow.

This evaluation aims to determine whether the compact camera system can provide imaging performance comparable to the traditional tower-based system while offering potential operational benefits. These benefits may include improved flexibility in space-constrained environments, reduced dependence on fixed equipment, and expanded opportunities for nasal endoscopy in clinics with limited infrastructure. Findings may inform future decisions regarding endoscopic equipment selection across various clinical settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasolacrimal Duct Obstruction Nasolacrimal Tract Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Modified Portable Endoscopic Camera

Modified Portable Endoscopic Camera

Intervention Type DEVICE

The Sony Action Camera was modified to allow direct coupling with a standard rigid nasal endoscope:

1. The native 180° wide-angle lens was replaced with a narrow-field 31° lens, enabling full-frame capture of the endoscopic image without peripheral distortion.
2. The camera housing was adapted by attaching a ¾-inch water pipe end connector, serving as a secure and stable mount for the endoscope eyepiece.

The modified system captures both video and still images.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified Portable Endoscopic Camera

The Sony Action Camera was modified to allow direct coupling with a standard rigid nasal endoscope:

1. The native 180° wide-angle lens was replaced with a narrow-field 31° lens, enabling full-frame capture of the endoscopic image without peripheral distortion.
2. The camera housing was adapted by attaching a ¾-inch water pipe end connector, serving as a secure and stable mount for the endoscope eyepiece.

The modified system captures both video and still images.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (18 years and older) presenting with tearing suggestive of nasolacrimal drainage obstruction
* Adult patients presenting with sinunasal disease with clinical findings on endonasal examination.
* Adult patients who require a clinically ordered nasal endoscopic exam.

Exclusion Criteria

* Children (Under the age of 18)
* Patients with over secretory tearing.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Arkansas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Omar Solyman, MD

Role: PRINCIPAL_INVESTIGATOR

University Of Arkansas For Medical Sciences, Jones Eye Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Omar Solyman, MD

Role: CONTACT

501-296-1156

Sajida Chauhan, BA

Role: CONTACT

501-296-1156

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sajida Chauhan, BA

Role: primary

501-296-1156

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

299385

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nebulized Nasal Steroids
NCT07270302 NOT_YET_RECRUITING PHASE1/PHASE2